Device Trial Radar · NCT02890303
A Prospective Multi-Center Study of Anterior Lens Capsulotomy Using the Mynosys Zepto System
Last checked: Nov 20, 2026Latest source record: Apr 27, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
100
Actual
Start
Sep 12, 2016
Primary completion
Dec 15, 2016
Study completion Mar 14, 2017
Sponsor
- Lead sponsor
- Mynosys Cellular Devices, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 7, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate outcome in subjects who have elected to have Zepto capsulotomies during cataract surgery with phacoemulsification.
Conditions
- Cataract
Interventions
Zepto SystemDevice
Anterior Capsulotomy using the Zepto System.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Complete CapsulotomyTime frame: During surgery
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.